Armistice Capital LLC has recently announced that it has increased stake in Addex Therapeutics Ltd (NASDAQ:ADXN) by 26.47%. After grabbing 0.32 million shares, the institutional investor is now in possession of 66983.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 1.96% having worth around $0.25 million. Moreover, Renaissance Technologies LLC increased its share by 29547.0 to have a control over 29547.0 shares. And FNY Capital Management LP raised its holdings to 22500.0 shares by acquiring 22500.0 shares or 0.14% of the stake.
Addex Therapeutics Ltd (ADXN) concluded trading on 01/12/23 at a closing price of $0.84, with 0.43 million shares of worth about $0.36 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -14.29% during that period and on Thursday the price saw a gain of about 6.99%. Currently the company’s common shares owned by public are about 12.86M shares, out of which, 12.86M shares are available for trading.
A deeper look into what the analysts at Wall Street are thinking about the price target of this stock provides us with the following: 2 analysts are covering the ADXN stock and their offered price forecasts bring an average price target of $1.01. Over the next 12 months, analysts forecasted that the stock’s price could jump as high as $1.01 and could fall to a lowest price of $1.01. However, touching the estimated high of $1.01 would mean a gain of 16.83% for the stock.
Addex Therapeutics Ltd (NASDAQ: ADXN) started trading at $0.7693, below -$0.02 from concluding price of the previous day. However, the stock later moved at a day high price of 0.8475, or with a gain of 6.99%. Stock saw a price change of 13.12% in past 5 days and over the past one month there was a price change of 31.35%. Year-to-date (YTD), ADXN shares are showing a performance of 33.31% which decreased to -86.65% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.55 but also hit the highest price of $6.55 during that period. The average intraday trading volume for Addex Therapeutics Ltd shares is 148.94K. The stock is currently trading 29.29% above its 20-day simple moving average (SMA20), while that difference is up 16.97% for SMA50 and it goes to -55.50% lower than SMA200.
Armistice Capital LLC acquired 0.32 million shares of Addex Therapeutics Ltd having value of about $0.25 million. Data submitted at the U.S SEC by Armistice Capital LLC revealed that the firm now holds 66983.0 shares in the company valued at close to $56265.72, or have control over 26.47% stake in the company. Addex Therapeutics Ltd (NASDAQ: ADXN) currently have 12.86M outstanding shares and institutions hold larger chunk of about 47.62% of that. Holding of mutual funds in the company is about — while other institutional holders and individual stake holders have control over — and — of the stake respectively.
The stock has a current market capitalization of $18.37M. It has posted earnings per share of -$3.26 in the same period. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ADXN, volatility over the week remained 10.95% while standing at 10.18% over the month.
Analysts at 2 brokerage firms have issued recommendations for the Addex Therapeutics Ltd (ADXN)’s stock out of those 2 Wall Street analysts, 0 recommended a “Buy” rating, while 0 were in favor recommending the stock as a “Hold” and 1 analyst recommended the stock as “Sell”.